Compare RMTI & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RMTI | BHST |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | Canada |
| Employees | 300 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.1M | 33.1M |
| IPO Year | 2022 | 2017 |
| Metric | RMTI | BHST |
|---|---|---|
| Price | $6.00 | $1.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $20.00 | $8.25 |
| AVG Volume (30 Days) | 22.2K | ★ 31.7K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,258,000.00 | N/A |
| Revenue This Year | $5.09 | N/A |
| Revenue Next Year | $8.02 | $28.14 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.55 | $0.91 |
| 52 Week High | $8.90 | $7.20 |
| Indicator | RMTI | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 33.77 | 36.77 |
| Support Level | $0.78 | N/A |
| Resistance Level | $6.14 | $2.05 |
| Average True Range (ATR) | 0.59 | 0.19 |
| MACD | -0.13 | -0.04 |
| Stochastic Oscillator | 2.02 | 34.11 |
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.